The relative merits of the methods employed to determine enantiomeric excess (ee) values and absolute configurations of chiral arene and alkene cis-1,2-diol metabolites, including boronate formation, using racemic or enantiopure (+) and (−)-2-(1-methoxyethyl)phenylboronic acid (MEPBA), are discussed. group was on the structural/stereochemical identification of new cis-dihydrodiol metabolites, from monoand di-substituted benzene and polycyclic aromatic hydrocarbon substrates, using different dioxygenase enzymes. [1][2][3][4][5][6][7][8][9][10] The instability of arene cis-dihydrodiol metabolites, and their unavailability in sufficient quantities, were early barriers to their utilization in synthetic chemistry. [1][2][3][4][5][6][7][8] In 1983, the development of a proprietary constituent mutant strain of P. putida (UV4) by ICI, expressing toluene dioxygenase (TDO), led to the commercial production of arene cis-dihydrodiols, e.g., B (X = Y = H and X = Me, Y = H), and the first applications of this strain in synthesis.
11-13The availability of other mutant (Pseudomonas and Sphingomonas) and recombinant (Escherichia coli) strains, expressing TDO, naphthalene dioxygenase (NDO), biphenyl dioxygenase (BPDO), and benzoate dioxygenase for biotransformation resulted in a marked increase in worldwide interest in this type of bacterial metabolite. To date,